CEFTPool(15nmol;>70%)
ProductCode:PM-CEFT-1
PositiveControlPoolof27peptidesselectedfromdefinedHLAclassIandII-restrictedT-cellepitopesforTcellassays(e.g.ELISPOT).
Amount:1vialcontaining15nmol(appr.25µg)perpeptide
Purity:>70%(HPLC-MS)
DeliveryFormat:Freezedriedinambertypeglassvial
Application(s):T-cellassays,Immunemonitoring,AntigenspecificT-cellstimulation,T-cellexpansion,Cellularimmuneresponse
Indication(s)/Topic(s):Control
DeliveryTime:2-5days
PepMixes™PeptidePools
Theuseofcompleteprotein-spanningmixturesofoverlappingpeptides(PepMix™)isextremelyefficientforimmunostimulationofT-lymphocytesanddiagnosticapplications.InordertoestablishreliableandvalidatedT-cellassayssuchasELISPOT,appropriatepositiveandnegativecontrolsareessential.SelectionofsuchcontrolshelpstoconfirmproperfunctionalityoftheassayaswellasviABIlityofthecellsused.Inaddition,highqualitycontrolsaremostimportanttoestablishstandardizedassayprotocolsinclinicalsetups.Comparedtocommonlyusedcontrolslikephytohemagglutinin(PHA)andconcanavalinA(ConA)thatstimulateT-cellsaswellasothercelltypesorfulllengthantigens,syntheticpeptidepoolsoffertheadvantageofahighbatch-to-batchreproducibility,applicabilityofreliablechemicalandbiochemicalQC/QAmeasuresandshelfstabilitywhenstoredasfreezedriedaliquots.
BenefitsofPepMix™
-EquivalentorbetterstimulationofCD4+andCD8+T-cellresponsescomparedtowholeproteinantigens
-SimultaneousdetectionofCD4+andCD8+responsesinasinglesample
-ImprovedresponsesinstoredbloodandPBMcellscomparedtowholeproteinantigens
-Morereliableascontrolthanphytohemagglutinin(PHA)andconcanavalinA(ConA)
-High-batch-to-batchreproducibility
-Reliablechemicalandbiochemicalqualitycontrolandqualityassuranceforpeptidesynthesisandpeptidepoolgeneration
-Prolongedshelfstabilitywhenstoredfreezedried
CEFTPool(15nmol;>70%)
SelectedReferences
"StandardizationofCryopreservedPeripheralBloodMononuclearCellsThroughaRestingProcessforClinicalImmunomonitoring--DevelopmentofanAlgorithm"
Wangetal.,CytometryA.(2015)-PMID:26848928
"DichotomousEffectsofLatentCMVInfectiononthePhenotypeandFunctionalPropertiesofCD8+T-cellsandNK-cells"
Bigleyetal.,CellularImmunology(2015)-PMID:n.a
"K562-DerivedWhole-CellVaccineEnhancesAntitumorResponsesofCAR-RedirectedVirus-SpecificCytotoxicTLymphocytesInVivo"
Caruanaetal.,ClinCancerRes.(2015) -PMID:25691731
"Self-adjuvantedmRNAVaccinationinAdvancedProstateCancerPatients:aFirst-in-ManPhaseI/IIaStudy"
Kübleretal.,JImmunotherCancer.(2015)-PMID:26082837
"GuidelinesFortheAutomatedEvaluationofElispotAssays"
Janetzkietal.,NatureProtocols(2015)-PMID:26110715
"ProfilingTCellActivationUsingSingle-MoleculeFluorescenceInSituHybridizationandFlowCytometry"
Bushkinetal.,J.Immunol.(2015)-PMID:25505292
ApplicationNotes
"DevelopingMulti-HIVAntigenSpecificT-CellsasaComponentofaCureStrategy"
Lametal.(2015)Fulltext
"Peptide-stimulatedExpansionofVirus-specificTcellsForPreventativeTreatmentAfterAllogeneicStemCellTransplantation"
Garyetal.(2015)Fulltext
CEFTPool(15nmol;>70%)
| Application | AntigenspecificT-cellstimulation Immunemonitoring T-cellassays T-cellexpansion |
| ProteinName | Selectedproteins |
| Organism | Clostridiumtetani Epstein-Barrvirus(HHV-4) Humancytomegalovirus(HHV-5) InfluenzaA |
| Indication/Topic | Control |
| Numberofpeptides | 27 |
FurtherInformation:
| Amount | 1vialcontaining15nmol(appr.25µg)perpeptide |
| Specifications | DefinedHLAclassI&II-restrictedT-cellepitopes |
| Documentation | ProtocolandDatasheet |
| Sequence | SeeProductDatasheetunder ProductDocumentation |
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
通过解答，教会我，谢谢
A、Na2CO3HClH2SO4NaNO3
B、K2CO3H2SO4HNO3BaCl2
C、HClHNO3AgNO3NaCl
D、NaOHFeCl3MgCl2BaCl2
A.H2SO4Na2SO4AgNO3BaCl2.
B.NaOHNa2CO3NaHSO4MgCl2
C.CaCl2NaNO3MgSO4BaCl2
D.HNO3KOHKClK2CO3
2.NaNO3FeCl3AgNO3
分别有什么现象？谢谢回答！
C.MgCl2溶液和氨水D.盐酸和NaAlO2溶液
为什么
